Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers

Bibliographic Details
Main Authors:	Chairat, Kalayanee, Jittamala, Podjanee, Hanpithakpong, Warunee, Day, Nicholas P. J., White, Nicholas J., Pukrittayakamee, Sasithon, Tarning, Joel
Format:	Online
Language:	English
Published:	John Wiley and Sons Inc. 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876175/

Similar Items

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
by: Jittamala, Podjanee, et al.
Published: (2014)

Pharmacokinetic Interactions between Primaquine and Chloroquine
by: Pukrittayakamee, Sasithon, et al.
Published: (2014)

Chemical Analysis and Transplacental Transfer of Oseltamivir and Oseltamivir Carboxylic Acid in Pregnant Rats
by: Lin, Chia-Chun, et al.
Published: (2012)

Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
by: Jittamala, Podjanee, et al.
Published: (2014)

Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
by: Hanboonkunupakarn, Borimas, et al.
Published: (2014)

An in vitro study of elimination of oseltamivir carboxylate by haemofiltration
by: Gruber, P, et al.
Published: (2007)

Pharmacokinetics of oseltamivir in infants under the age of 1 year
by: Dixit, Rashmi, et al.
Published: (2016)

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design
by: Reddy, Micaela B., et al.
Published: (2015)

Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border
by: Kloprogge, Frank, et al.
Published: (2015)

Assay to Detect Oseltamivir Resistance
by: Suwannakarn, Kamol, et al.
Published: (2006)

Rapid Emergence of Oseltamivir Resistance
by: Sy, Cheng Len, et al.
Published: (2010)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
by: Anekthananon, T., et al.
Published: (2013)

Bench to Bed Evidences for Pharmacokinetic and Pharmacodynamic Interactions Involving Oseltamivir and Chinese Medicine
by: Chang, Qi, et al.
Published: (2014)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
by: Awab, Ghulam Rahim, et al.
Published: (2016)

Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications
by: Hoglund, Richard M, et al.
Published: (2015)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan
by: Hoglund, Richard M, et al.
Published: (2012)

Adverse drug reaction of oseltamivir in pediatric patients
by: Wiwanitkit, Somsri, et al.
Published: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
by: Wiwanitkit, Viroj
Published: (2009)

Adverse drug reaction profile of oseltamivir in children
by: Dalvi, Prashant S., et al.
Published: (2011)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
by: Fietjé, Esther H., et al.
Published: (2012)

The mechanisms of sudden‐onset type adverse reactions to oseltamivir
by: Hama, R., et al.
Published: (2016)

The mechanisms of delayed onset type adverse reactions to oseltamivir
by: Hama, Rokuro
Published: (2016)

Oseltamivir use amongst hospitalized patients infected with influenza
by: Herman, Michael, et al.
Published: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
by: Hurt, Aeron C., et al.
Published: (2016)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks
by: Anekthananon, T., et al.
Published: (2013)

Oseltamivir (Tamiflu®) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans – a review
by: Järhult, Josef D.
Published: (2012)

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
by: Hurt, Aeron C., et al.
Published: (2013)

Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study
by: Zhang, Yan, et al.
Published: (2016)

A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination
by: Morrison, Dennis, et al.
Published: (2007)

Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug
by: Kim, Dong Ki, et al.
Published: (2014)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
by: Cheng, Peter K.C., et al.
Published: (2009)

Molecular Dynamics Studies Of The Effects Of Neuraminidase Mutation On Oseltamivir Resistance
by: Muhammad Yusuf, Muhammad Yusuf
Published: (2015)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
by: Ramirez-Gonzalez, José Ernesto, et al.
Published: (2011)

Health care personnel and risk of H1N1-chemoprophylaxis with oseltamivir
by: Samra, Tanvir, et al.
Published: (2012)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
by: Tuna, Nazan, et al.
Published: (2012)

Health care personnel and risk of H1N1-chemoprophylaxis with oseltamivir
by: Wiwanitkit, Viroj
Published: (2013)

Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
by: Zhang, Yingjie, et al.
Published: (2013)

THE CLINICAL AND LABORATORY EFFECTIVENESS OF OSELTAMIVIR FOR TREATMENT OF INFLUENZA IN HOSPITALIZED PATIENTS
by: L. V. Voloschcuk, et al.
Published: (2015-01-01)

Oseltamivir Expands Quasispecies of Influenza Virus through Cell-to-cell Transmission
by: Mori, Kotaro, et al.
Published: (2015)

Oseltamivir (Tamiflu)-induced bilateral acute angle closure glaucoma and transient myopia
by: Lee, Ji Woong, et al.
Published: (2014)